CLICHY, France--(BUSINESS WIRE)--CorWave raised 61 million euros to fund its first industrial deployment and entry into clinical trials. SPI fund, managed by Bpifrance on behalf of the French ...
First-of-its-kind heart pump implanted in Australia, based on a breakthrough wave membrane technology. Unlike existing devices, CorWave’s technology does not eliminate the effects of the native ...
CorWave Announces the Appointment of Dawn Sadlowski-Buisserez as Vice President of Operations to Support the Ramp-Up of Production CorWave, a French company developing and manufacturing innovative ...
Primary endpoint successfully met, no device-related serious adverse events at 30 days Pulsatility preserved throughout the study with beat-to-beat valve opening Successful transplantation after 84 ...
Corwave SA raised €26 million (US$28 million) in the second close of its series C funding round taking the total amount to €61 million. The funds will go toward the industrial development of the ...
CLICHY, France--(BUSINESS WIRE)--CorWave reported today it has raised $40M from returning investors and three new investors. The company is developing an implantable heart pump (Left Ventricular ...
COPENHAGEN, Denmark, Jan. 6, 2021 /PRNewswire/ -- Novo Seeds, the early stage investment and company creation team of Novo Holdings, announced today that its portfolio company CorWave, a medtech ...
CorWave reported today it has raised $40M from returning investors and three new investors. The company is developing an implantable heart pump (Left Ventricular Assist Device, LVAD) based on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback